Stock comparison
AGILENT TECHNOLOGIES, INC. is 4.7x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.75 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
A is larger
AGILENT TECHNOLOGIES, INC. is 4.7x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.75 B vs $8.09 B).
Market value leader
A
AGILENT TECHNOLOGIES, INC. is 4.7x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.75 B vs $8.09 B).
Revenue leader
A
A: $6.95B vs BIO: $2.58B.
Profit leader
A
A: $1.30B vs BIO: $759.90M.
Margin leader
BIO
A: 18.8% vs BIO: 29.4% net margin.
| Metric | A | BIO |
|---|---|---|
| Market cap | $37.75 B | $8.09 B |
| US-listed rank | #404 | #1080 |
| Revenue (latest FY) | $6.95B | $2.58B |
| Net income (latest FY) | $1.30B | $759.90M |
| Net margin | 18.8% | 29.4% |
| P/E (trailing FY) | 29.0x | 10.6x |
| SEC filings | 2,339 | 1,494 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AGILENT TECHNOLOGIES, INC. is 4.7x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($37.75 B vs $8.09 B).
In their latest fiscal years, AGILENT TECHNOLOGIES, INC. reported $6.95B in revenue while Bio-Rad Laboratories, Inc. reported $2.58B.
Full pages: AGILENT TECHNOLOGIES, INC. and Bio-Rad Laboratories, Inc., or browse the full rankings.